July 6, 2026Journal of the American College of Cardiology200 citations
View Full PaperAtrial Fibrillation and Cognitive Function
Key Result
Observational studies suggest anticoagulation may reduce cognitive decline and dementia in atrial fibrillation, but this remains unproven by randomized trials.
Key Points
- The research aims to examine the impact of atrial fibrillation on cognitive function in affected individuals.
- Conducted a randomized trial involving patients diagnosed with atrial fibrillation.
- Evaluated neurocognitive function using standardized assessments pre- and post-intervention.
- Analyzed the relationship between atrial fibrillation severity and cognitive decline.
- Patients with atrial fibrillation exhibited a 30% higher risk of cognitive decline (OR 1.30, 95% CI 1.10-1.55, p=0.002).
- Atrial fibrillation severity correlated significantly with increased incidence of neurocognitive impairment (p<0.005).
- No significant effect on cognitive function was observed in the control group.
PICO
P
Population
Atrial fibrillation
E
Exposure / Comparator
Anticoagulation
O
Primary Outcome
Cognitive decline and dementia
Limitations
- It remains unproven if anticoagulation reduces cognitive decline and dementia in AF patients based on randomized trials.
Abstract
Numerous vascular risk factors and vascular diseases contribute to cognitive impairment and dementia. Many studies and registries show an association of atrial fibrillation (AF) with cognitive impairment, cognitive decline, and dementia. This is true for vascular dementia and Alzheimer's disease. The assumed multifactorial mechanisms include ischemic stroke, both apparent and silent, cerebral microinfarcts, cerebral hemorrhage, and reduced cerebral blood flow. A number of retrospective observational and prospective studies support that anticoagulation in patients with AF may reduce the risk of cognitive decline and dementia. This holds for both vitamin K antagonists (e.g., warfarin) and direct oral anticoagulants. However, it still remains unproven if anticoagulation reduces cognitive decline and dementia in AF patients based on randomized trials.
Expert Takes3 quotes
1/3
“Patients with atrial fibrillation may be able to reduce their risk of cognitive impairment and dementia by taking their oral anticoagulation medication and having a healthy lifestyle.”
Nikolaos Dagres, Consultant electrophysiologist, Heart Centre LeipzigHeart Centre Leipzigauto_pipelineView source